Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | PDGFRB |
| Variant | E563_I564del |
| Impact List | deletion |
| Protein Effect | gain of function - predicted |
| Gene Variant Descriptions | PDGFRB E563_I564del results in the deletion of two amino acids in the cytoplasmic domain of the Pdgfrb protein from amino acids 563 to 564 (UniProt.org). E563_I564del results in increased phosphorylation of Pdgfrb in culture (PMID: 38741091), and therefore, is predicted to lead to a gain of Pdgfrb protein function. |
| Associated Drug Resistance | |
| Category Variants Paths |
PDGFRB mutant PDGFRB act mut PDGFRB E563_I564del |
| Transcript | NM_002609.4 |
| gDNA | chr5:g.150125561_150125566delATCTCG |
| cDNA | c.1687_1692delGAGATC |
| Protein | p.E563_I564del |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_002609.4 | chr5:g.150125561_150125566delATCTCG | c.1687_1692delGAGATC | p.E563_I564del | RefSeq | GRCh38/hg38 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|